ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2972

Multicentric Reticulohistiocytosis (1980-2017): A Rare Disease, Commonly Associated with Malignancy and Autoimmunity

Avneek Singh Sandhu1, Cynthia S. Crowson2, David Wetter3, Gavin McKenzie4 and Ashima Makol1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 3Dermatology, Mayo Clinic, Rochester, MN, 4Radiology, Mayo Clinic, Rochester, MN

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthritis, autoimmune diseases, histopathologic, malignancy and multicentric reticulohistiocytosis

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, October 24, 2018

Session Title: 6W021 ACR Abstract: Misc Rheumatic & Inflam DZ II (2970–2975)

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Multicentric reticulohistiocytosis (MRH) is a systemic disease characterized by papulo-nodular skin eruptions and progressive, deforming arthritis. We aimed to examine the clinical correlates and outcomes of MRH seen at our center, and study the association with malignancy and autoimmunity.

Methods: A retrospective cohort of MRH patients treated at our institution from 01/01/1980 to 04/30/2017 was assembled. Demographics, clinical features, laboratory tests, imaging findings, histopathology (HP), treatments and outcomes were abstracted. Autoimmune (AI) disorders and malignancies before and after MRH diagnosis were collected.

Results: We identified 24 patients with MRH (58% female, 75% Caucasian, mean age at diagnosis 52y) with median follow up of 2.3 y. All patients had confirmed diagnosis by HP (23 skin, 7 synovial) and had cutaneous & articular involvement. Nodular skin lesions were noted in 96% patients (periungual area & dorsal hand in 87%, periarticular 61%, face 54%, arms 42%, back 29%, neck 21%, legs 21%, ears 12%, scalp 12%) and mucosal nodules in 30% patients. 92% patients had arthralgia, 88% had joint swelling, and 54% had synovitis. Frequency of joint involvement was upper extremity (UE) PIP(29%)> UE DIPs, MCPs, wrist>MTPs, Toes>Knees>Elbows. Radiographic erosions were noted in 67% patients. Constitutional symptoms included fatigue(15), unintentional weight loss(10),lymphadenopathy(4) and pruritis(11). Systemic features included dysphagia(5), photosensitivity(4), dry eyes(3), and serositis(3). Several patients had positive serologies: ANA(8), RF(5), CCP(3), SSA(3), SSB(2), dsDNA(1). A third of patients had concomitant AI disorders(RA[3], SS[1], chronic focal granulomatous nephritis[1], JIA[1], psoriasis[1], myasthenia gravis and ITP[1]) and 1/3rd had malignancy(melanoma{3], basal cell carcinoma[2], and 1 each with ovarian carcinoma, squamous cell carcinoma lung, peritoneal adenocarcinoma, and endometrial carcinoma). Most patients were treated with systemic CS(15) and DMARDs(13): MTX(8), CYC(10), chlorambucil(2) and CSA(1). Biologics (infliximab, etanercept, adalimumab) were used in 4 patients. 2 patients had complete resolution of symptoms, while majority showed only partial improvement. 10 patients developed joint deformities involving: wrist(4), MCP(4), PIP(7), DIP(4), MTP(3), and knee(2). None had arthritis mutilans. 75% were alive at last follow up.

 

Conclusion: To our knowledge, this is the largest series of MRH patients from a single institution, highlighting the rarity of the condition, and an unmet need for treatment options that can allow sustained disease remission. We emphasize the need for HP to distinguish it from mimicking rheumatic conditions and initiating early aggressive treatment to potentially prevent deforming arthritis. A high vigilance for malignancy and other AI diseases is necessary.


Disclosure: A. S. Sandhu, None; C. S. Crowson, None; D. Wetter, None; G. McKenzie, None; A. Makol, None.

To cite this abstract in AMA style:

Sandhu AS, Crowson CS, Wetter D, McKenzie G, Makol A. Multicentric Reticulohistiocytosis (1980-2017): A Rare Disease, Commonly Associated with Malignancy and Autoimmunity [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/multicentric-reticulohistiocytosis-1980-2017-a-rare-disease-commonly-associated-with-malignancy-and-autoimmunity/. Accessed May 17, 2022.
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multicentric-reticulohistiocytosis-1980-2017-a-rare-disease-commonly-associated-with-malignancy-and-autoimmunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.